{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:27:30Z","timestamp":1787502450363,"version":"build-2736575974"},"reference-count":136,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.critrevonc.2012.09.014","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T12:33:22Z","timestamp":1350995602000},"page":"232-250","source":"Crossref","is-referenced-by-count":153,"title":["Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis"],"prefix":"10.1016","volume":"86","author":[{"given":"Jayshree","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohel H.","family":"Quazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Sridhar","family":"Karanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2012.09.014_bib0005","doi-asserted-by":"crossref","first-page":"e11700","DOI":"10.1371\/journal.pone.0011700","article-title":"Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells","volume":"5","author":"Kaler","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0010","unstructured":"Colorectal Cancer Screening. Rockville (MD); 1998."},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00384-011-1393-3","article-title":"In vitro biocompatibility of thermally gelling liquid mucoadhesive loaded curcuminoids in colorectal cancer chemoprevention","volume":"7","author":"Chen","year":"2012","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0020","first-page":"142","article-title":"Diet, lifestyle, and colon cancer","volume":"11","author":"Slattery","year":"2000","journal-title":"Seminars in Gastrointestinal Disease"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00384-003-0485-0","article-title":"Environmental factors affect colon carcinoma and rectal carcinoma in men and women differently","volume":"18","author":"Nakaji","year":"2003","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0030","doi-asserted-by":"crossref","first-page":"3109S","DOI":"10.1093\/jn\/131.11.3109S","article-title":"Insulin, insulin-like growth factors and colon cancer: a review of the evidence","volume":"131","author":"Giovannucci","year":"2001","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0035","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.critrevonc.2010.02.003","article-title":"Global graying, colorectal cancer and liver metastasis: new implications for surgical management","volume":"77","author":"Anaya","year":"2011","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/PPO.0b013e3181e076af","article-title":"Biology of colorectal cancer","volume":"16","author":"Saif","year":"2010","journal-title":"Cancer Journal"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0045","first-page":"85","article-title":"JC virus and colorectal cancer: a possible trigger in the chromosomal instability pathways","volume":"21","author":"Niv","year":"2005","journal-title":"Current Opinion in Gastroenterology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0050","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-3-642-30331-9_9","article-title":"Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC)","volume":"191","author":"Burn","year":"2012","journal-title":"Recent Results in Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(00)05257-0","article-title":"Common hereditary cancers and implications for primary care","volume":"358","author":"Emery","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annual Review of Pathology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0070","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/onc.2010.89","article-title":"Oncogenic mutations as predictive factors in colorectal cancer","volume":"29","author":"Lievre","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0075","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1245\/s10434-009-0811-z","article-title":"KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy","volume":"17","author":"Siddiqui","year":"2010","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0080","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/cncr.25630","article-title":"Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers","volume":"117","author":"Baba","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1593\/neo.04571","article-title":"Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth","volume":"7","author":"Corvinus","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1476-4598-9-217","article-title":"A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells","volume":"9","author":"Lin","year":"2010","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0095","first-page":"964","article-title":"The adult well male examination","volume":"85","author":"Heidelbaugh","year":"2012","journal-title":"American Family Physician"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.critrevonc.2009.11.002","article-title":"Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study","volume":"76","author":"Kristjansson","year":"2010","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0105","first-page":"S23","article-title":"Managing potentially resectable metastatic colon cancer","volume":"2","author":"Marshall","year":"2008","journal-title":"Gastrointestinal Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0110","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jjco\/hyn116","article-title":"Polymeric micellar delivery systems in oncology","volume":"38","author":"Matsumura","year":"2008","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/14712590802715756","article-title":"Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer","volume":"9","author":"Morse","year":"2009","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0120","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1634\/theoncologist.2008-0166","article-title":"Cancer and immune response: old and new evidence for future challenges","volume":"13","author":"de la Cruz-Merino","year":"2008","journal-title":"The Oncologist"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0125","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1055\/s-0028-1091251","article-title":"Immunotherapy for cancer \u2013 modern immunologic strategies in oncology","volume":"133","author":"Halama","year":"2008","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0130","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2217\/imt.11.114","article-title":"Conference scene: immunotherapy reaches new milestones in cancer eradication","volume":"3","author":"Kotlan","year":"2011","journal-title":"Immunotherapy"},{"issue":"5","key":"10.1016\/j.critrevonc.2012.09.014_bib0135","doi-asserted-by":"crossref","first-page":"C735","DOI":"10.1152\/ajpcell.00316.2011","article-title":"Molecular mechanism of interleukin-2-induced mucosal homeostasis","volume":"302","author":"Mishra","year":"2012","journal-title":"American Journal of Physiology: Cell Physiology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/med.20110","article-title":"Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines","volume":"28","author":"Mocellin","year":"2008","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0145","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0150","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1158\/0008-5472.CAN-09-4354","article-title":"Tumor-initiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice","volume":"70","author":"Soudja","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0155","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00262-011-1053-z","article-title":"Cooperativity of adaptive and innate immunity: implications for cancer therapy","volume":"60","author":"Shanker","year":"2011","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0160","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0165","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0170","first-page":"687","article-title":"Immune based therapies in cancer","volume":"22","author":"Kruger","year":"2007","journal-title":"Histology and Histopathology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00262-011-1039-x","article-title":"Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy","volume":"61","author":"van de Ven","year":"2012","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0180","first-page":"255","article-title":"Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative","volume":"73","author":"Limpens","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0185","first-page":"285","article-title":"Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer","volume":"9","author":"Yu","year":"2003","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/138920109787315114","article-title":"Targeting the immune system in cancer","volume":"10","author":"Chaudhuri","year":"2009","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0195","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","article-title":"Active targeting schemes for nanoparticle systems in cancer therapeutics","volume":"60","author":"Byrne","year":"2008","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canlet.2008.07.030","article-title":"Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer","volume":"273","author":"Li","year":"2009","journal-title":"Cancer Letters"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0205","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.addr.2008.03.007","article-title":"Ultrasound mediated delivery of drugs and genes to solid tumors","volume":"60","author":"Frenkel","year":"2008","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0210","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1349-7006.2008.00878.x","article-title":"Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers","volume":"99","author":"Kyo","year":"2008","journal-title":"Cancer Science"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ijc.23692","article-title":"Oncolytic virotherapy as a personalized cancer vaccine","volume":"123","author":"Li","year":"2008","journal-title":"International Journal of Cancer: Journal International du Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0220","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1158\/0008-5472.CAN-08-1688","article-title":"\u201cActive\u201d cancer immunotherapy by anti-Met antibody gene transfer","volume":"68","author":"Vigna","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/path.2493","article-title":"Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice","volume":"217","author":"Chen","year":"2009","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/cgt.2008.46","article-title":"An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors","volume":"16","author":"Lei","year":"2009","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0235","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.cgt.7700944","article-title":"Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter","volume":"13","author":"Davis","year":"2006","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0240","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1158\/1541-7786.MCR-07-0073","article-title":"Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy","volume":"6","author":"Su","year":"2008","journal-title":"Molecular Cancer Research: MCR"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cgt.2008.3","article-title":"Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model","volume":"15","author":"Huang","year":"2008","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0250","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/cgt.2008.33","article-title":"Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy","volume":"15","author":"Gao","year":"2008","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0255","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbrc.2008.06.055","article-title":"HVJ envelope vector, a versatile delivery system: its development, application, and perspectives","volume":"373","author":"Zhang","year":"2008","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0260","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/187221508783406594","article-title":"Patents on non-viral mediated gene delivery","volume":"2","author":"Goyal","year":"2008","journal-title":"Recent Patents on DNA & Gene Sequences"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10611860801900801","article-title":"Chitosan-mediated orally delivered nucleic acids: a gutful of gene therapy","volume":"16","author":"Dass","year":"2008","journal-title":"Journal of Drug Targeting"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0270","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/gt.2008.6","article-title":"Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil","volume":"15","author":"Chu","year":"2008","journal-title":"Gene Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.critrevonc.2009.06.005","article-title":"Integration of panitumumab into the treatment of colorectal cancer","volume":"74","author":"Gravalos","year":"2010","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0280","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.critrevonc.2009.07.005","article-title":"Improving disease control in advanced colorectal cancer: panitumumab and cetuximab","volume":"74","author":"Rodriguez","year":"2010","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0761-8417(07)90085-1","article-title":"New biological treatments for lung cancer","volume":"63","author":"Zalcman","year":"2007","journal-title":"Revue de Pneumologie Clinique"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0290","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri2744","article-title":"Monoclonal antibodies: versatile platforms for cancer immunotherapy","volume":"10","author":"Weiner","year":"2010","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0295","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.it.2011.07.003","article-title":"Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy","volume":"32","author":"Houot","year":"2011","journal-title":"Trends in Immunology"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.09.014_bib0300","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/ijc.25851","article-title":"Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells","volume":"109","author":"Weng","year":"2011","journal-title":"International Journal of Cancer: Journal International du Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4049\/jimmunol.1002067","article-title":"Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors","volume":"187","author":"Iwata-Kajihara","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0310","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0315","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm1039","article-title":"Dendritic cell immunotherapy: mapping the way","volume":"10","author":"Figdor","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0320","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2008.08.004","article-title":"Cancer immunotherapy by dendritic cells","volume":"29","author":"Melief","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0325","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2007.00575.x","article-title":"Taming cancer by inducing immunity via dendritic cells","volume":"220","author":"Palucka","year":"2007","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0330","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2741\/2814","article-title":"Dendritic cell based personalized immunotherapy based on cancer antigen research","volume":"13","author":"Kawakami","year":"2008","journal-title":"Frontiers in Bioscience: A Journal and Virtual Library"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0340","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2891-10-89","article-title":"Fermented wheat germ extract \u2013 nutritional supplement or anticancer drug?","volume":"10","author":"Mueller","year":"2011","journal-title":"Nutrition Journal"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-2187-6-7","article-title":"Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells","volume":"6","author":"Nautiyal","year":"2011","journal-title":"Journal of Molecular Signaling"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0350","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/bjc.2011.200","article-title":"Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030","volume":"105","author":"Lin","year":"2011","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0355","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00280-011-1641-9","article-title":"Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation","volume":"68","author":"Xavier","year":"2011","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0360","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/01635581.2011.535954","article-title":"Quercetin's effects on intestinal polyp multiplicity and macrophage number in the Apc(Min\/+) mouse","volume":"63","author":"Murphy","year":"2011","journal-title":"Nutrition and Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0365","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/carcin\/bgi089","article-title":"Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin)","volume":"26","author":"Volate","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0370","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1080\/01635581.2011.601846","article-title":"Diallyl disulphide, a beneficial component of garlic oil, causes a redistribution of cell-cycle growth phases, induces apoptosis, and enhances butyrate-induced apoptosis in colorectal adenocarcinoma cells (HT-29)","volume":"63","author":"Altonsy","year":"2011","journal-title":"Nutrition and Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0375","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00204-011-0748-4","article-title":"Diallyl disulfide induces Ca2+ mobilization in human colon cancer cell line SW480","volume":"86","author":"Chen","year":"2012","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0380","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ijc.26078","article-title":"Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer \u2013 a review","volume":"129","author":"Dhayat","year":"2011","journal-title":"International Journal of Cancer: Journal International du Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0385","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0390","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0395","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1242\/dev.02070","article-title":"microPrimer: the biogenesis and function of microRNA","volume":"132","author":"Du","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0400","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","article-title":"Asymmetry in the assembly of the RNAi enzyme complex","volume":"115","author":"Schwarz","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0405","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1126\/science.1073827","article-title":"A microRNA in a multiple-turnover RNAi enzyme complex","volume":"297","author":"Hutvagner","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0410","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1101\/gad.1187904","article-title":"RISC is a 5\u2032 phosphomonoester-producing RNA endonuclease","volume":"18","author":"Martinez","year":"2004","journal-title":"Genes & Development"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0415","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer","volume":"27","author":"Asangani","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0420","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1248\/bpb.29.903","article-title":"let-7 microRNA functions as a potential growth suppressor in human colon cancer cells","volume":"29","author":"Akao","year":"2006","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0425","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-08-0325","article-title":"Epigenetic silencing of microRNA-34b\/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer","volume":"68","author":"Toyota","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0430","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/cgt.2008.104","article-title":"Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A","volume":"16","author":"Mook","year":"2009","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0435","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s11033-008-9318-0","article-title":"Silencing GIRK4 expression in human atrial myocytes by adenovirus-delivered small hairpin RNA","volume":"36","author":"Liu","year":"2009","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0440","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2006.09.002","article-title":"Suppression of tumor growth by intratumoral injection of short hairpin RNA-expressing plasmid DNA targeting beta-catenin or hypoxia-inducible factor 1alpha","volume":"116","author":"Takahashi","year":"2006","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0445","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/oli.2006.0054","article-title":"Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture model","volume":"17","author":"Chaturvedi","year":"2007","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0450","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI37515","article-title":"Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice","volume":"119","author":"Judge","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0455","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jgm.1207","article-title":"Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice","volume":"10","author":"Rauschhuber","year":"2008","journal-title":"The Journal of Gene Medicine"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0460","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/ijc.22856","article-title":"Adenovirus-mediated small hairpin RNA targeting Bcl-XL as therapy for colon cancer","volume":"121","author":"Zhu","year":"2007","journal-title":"International Journal of Cancer: Journal International du Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0465","doi-asserted-by":"crossref","first-page":"12236","DOI":"10.1128\/JVI.01205-06","article-title":"Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing","volume":"80","author":"Narvaiza","year":"2006","journal-title":"Journal of Virology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0470","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1248\/yakushi.127.1525","article-title":"In vivo siRNA delivery to tumor cells and its application to cancer gene therapy","volume":"127","author":"Takahashi","year":"2007","journal-title":"Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0475","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gt.2008.3","article-title":"Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition","volume":"15","author":"Yoo","year":"2008","journal-title":"Gene Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0480","doi-asserted-by":"crossref","first-page":"28945","DOI":"10.1155\/JBB\/2006\/28945","article-title":"Adenovirus-mediated in vivo silencing of anaphylatoxin receptor C5aR","volume":"2006","author":"Sun","year":"2006","journal-title":"Journal of Biomedicine & Biotechnology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0485","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jcp.21679","article-title":"An shRNA silencing a non-toxic transgene reduces nutrient consumption and increases production of adenoviral vectors in a novel packaging cell","volume":"219","author":"Wang","year":"2009","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0490","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1038\/sj.onc.1208511","article-title":"Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations","volume":"24","author":"He","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0495","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1021\/nn800716j","article-title":"Composite nanoparticles take aim at cancer","volume":"2","author":"Gil","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0500","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nature Reviews: Drug discovery"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0505","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijpharm.2008.08.005","article-title":"Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells","volume":"364","author":"Schiffelers","year":"2008","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0510","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jgm.1006","article-title":"siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing","volume":"9","author":"Cardoso","year":"2007","journal-title":"The Journal of Gene Medicine"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0515","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2008.03.008","article-title":"Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer","volume":"129","author":"Kim","year":"2008","journal-title":"Journal of Controlled Release: Official Journal of the Controlled Release Society"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0520","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1007\/s11095-008-9693-1","article-title":"Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response","volume":"25","author":"Bonnet","year":"2008","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0525","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/bc800436v","article-title":"Acid-responsive linear polyethylenimine for efficient, specific, and biocompatible siRNA delivery","volume":"20","author":"Shim","year":"2009","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0530","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/sj.gt.3301492","article-title":"Chitosan as a nonviral gene delivery system. Structure\u2013property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo","volume":"8","author":"Koping-Hoggard","year":"2001","journal-title":"Gene Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0535","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/jpp.61.01.0002","article-title":"Cancer, chitosan nanoparticles and catalytic nucleic acids","volume":"61","author":"Tan","year":"2009","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0540","doi-asserted-by":"crossref","first-page":"30341","DOI":"10.1074\/jbc.C600319200","article-title":"Janus kinase 3 regulates interleukin 2-induced mucosal wound repair through tyrosine phosphorylation of villin","volume":"282","author":"Kumar","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0685","doi-asserted-by":"crossref","unstructured":"Mishra J, Karanki SS, Kumar N. Identification of molecular switch regulating interactions of janus kinase 3 with cytoskeletal proteins. Journal of Biological Chemistry 2012, in press.","DOI":"10.1074\/jbc.C112.363507"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0550","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02065426","article-title":"Autoantibodies specific for villin found in patients with colon cancer and other colitides","volume":"40","author":"Rimm","year":"1995","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0555","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/sj.onc.1203925","article-title":"Janus kinases: components of multiple signaling pathways","volume":"19","author":"Rane","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0560","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2217\/pgs.10.4","article-title":"Pharmacogenomics in the treatment of inflammatory bowel disease","volume":"11","author":"Smith","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0565","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1440-1843.2007.01105.x","article-title":"Lung cancer: future directions","volume":"12","author":"Lam","year":"2007","journal-title":"Respirology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0570","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2741\/1429","article-title":"Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications","volume":"9","author":"Chu","year":"2004","journal-title":"Frontiers in Bioscience: A Journal and Virtual Library"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0575","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/156800911795538066","article-title":"Cytokines, inflammation and colon cancer","volume":"11","author":"Klampfer","year":"2011","journal-title":"Current Cancer Drug Targets"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0580","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000071375","article-title":"Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials","volume":"37","author":"Hawk","year":"2003","journal-title":"Progress in Experimental Tumor Research"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0585","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.bjp.0704365","article-title":"COX-2 and cancer: a new approach to an old problem","volume":"134","author":"Bakhle","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0590","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1572-0241.2002.05435.x","article-title":"Chemoprevention of colorectal cancer","volume":"97","author":"Gwyn","year":"2002","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0595","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s004320000225","article-title":"Cyclooxygenase-2: a novel target for cancer chemotherapy?","volume":"127","author":"Dempke","year":"2001","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0600","first-page":"M69","article-title":"Cyclooxygenase-2 and carcinogenesis","volume":"1470","author":"Prescott","year":"2000","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0605","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0165-6147(02)00043-3","article-title":"Cyclooxygenase 2: a molecular target for cancer prevention and treatment","volume":"24","author":"Subbaramaiah","year":"2003","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0610","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3816\/CBC.2008.n.024","article-title":"Beyond cytotoxic chemotherapy for the first-line treatment of HER2-negative, hormone-insensitive metastatic breast cancer: current status and future opportunities","volume":"8","author":"Conlin","year":"2008","journal-title":"Clinical Breast Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0615","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00262-008-0505-6","article-title":"Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity","volume":"57","author":"Menard","year":"2008","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0620","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tibtech.2008.10.006","article-title":"Cytotoxicity and immunostimulation: double attack on cancer cells with polymeric therapeutics","volume":"27","author":"Rihova","year":"2009","journal-title":"Trends in Biotechnology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0625","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00262-008-0576-4","article-title":"Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy","volume":"58","author":"Baxevanis","year":"2009","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0630","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00262-008-0598-y","article-title":"Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer","volume":"58","author":"Zhang","year":"2009","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0635","first-page":"37","article-title":"Combining radiation and immunotherapy for synergistic antitumor therapy","volume":"11","author":"Ferrara","year":"2009","journal-title":"Current Opinion in Molecular Therapeutics"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0640","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/138161209787315765","article-title":"Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics","volume":"15","author":"Louis","year":"2009","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0645","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/cgt.2008.89","article-title":"High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome","volume":"16","author":"Grinshtein","year":"2009","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0650","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.humimm.2008.12.004","article-title":"Antiviral cellular immunity in colorectal cancer patients","volume":"70","author":"Kiewe","year":"2009","journal-title":"Human Immunology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0655","first-page":"31","article-title":"Cancer vaccines: current directions and perspectives in prostate cancer","volume":"11","author":"Mohebtash","year":"2009","journal-title":"Current Opinion in Molecular Therapeutics"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0660","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00262-008-0480-y","article-title":"Cancer treatment: the combination of vaccination with other therapies","volume":"57","author":"Andersen","year":"2008","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0665","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1470-2045(06)70985-8","article-title":"Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited","volume":"8","author":"Gabrilovich","year":"2007","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0670","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/1078-0432.CCR-09-2046","article-title":"K562\/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate","volume":"16","author":"Smith","year":"2010","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0675","doi-asserted-by":"crossref","first-page":"267539","DOI":"10.1155\/2011\/267539","article-title":"Current immunotherapeutic approaches in pancreatic cancer","volume":"2011","author":"Koido","year":"2011","journal-title":"Clinical & Developmental Immunology"},{"key":"10.1016\/j.critrevonc.2012.09.014_bib0680","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1097\/00005537-200312000-00031","volume":"113","author":"Timar","year":"2003","journal-title":"Laryngoscope"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812001977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812001977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T19:04:36Z","timestamp":1562267076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842812001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":136,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1040842812001977"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2012.09.014","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}